Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03363893
Title Modular Study to Evaluate CT7001 Alone in Cancer Patients With Advanced Malignancies
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Carrick Therapeutics Limited
Indications

Her2-receptor negative breast cancer

lung small cell carcinoma

triple-receptor negative breast cancer

prostate cancer

Advanced Solid Tumor

ovarian cancer

Therapies

ICEC0942

Fulvestrant + ICEC0942

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.